Radiotherapy and adjuvant temozolomide compared with radiotherapy and concomitant plus adjuvant temozolomide in surgically treated patients with glioblastoma multiforme: a retrospective single institution study

M. Göppert, M. Rapp, J. Felsberg, W. Stummer, G. Reifenberger, H.-J. Steiger & M. Sabel
Objective: The benefit of the introduction of alkylating chemotherapy in treatment of glioblastoma multiforme (GBM) patients has recently been demonstrated by the comparison of radiotherapy with concomitant plus adjuvant temozolomide to radiation therapy alone. The impact of the concomitant part of [for full text, please go to the a.m. URL]